These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18696070)

  • 1. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
    Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
    Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of phosphotyrosine in bcr-abl-positive cells with PY20 antibody and its clinical applications].
    Zhu HH; Liu YR; Qin YZ; Chang Y; Li JL; Ruan GR; Jiang B; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):441-4. PubMed ID: 17147244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method.
    Shi Y; Li LZ; Sun JZ; Zhang T; Peng J; Xu CG
    Ann Hematol; 2008 Jan; 87(1):35-41. PubMed ID: 17846772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic efficacy for measurement of real-time quantitative PCR-based major bcr/abl mRNA in patients with Philadelphia chromosome-positive leukemia].
    Takahata M; Hashino S; Fujisawa F; Kondo T; Ota S; Kobayashi S; Tanaka J; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Dec; 45(12):1241-6. PubMed ID: 15678915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.
    Weerkamp F; Dekking E; Ng YY; van der Velden VH; Wai H; Böttcher S; Brüggemann M; van der Sluijs AJ; Koning A; Boeckx N; Van Poecke N; Lucio P; Mendonça A; Sedek L; Szczepański T; Kalina T; Kovac M; Hoogeveen PG; Flores-Montero J; Orfao A; Macintyre E; Lhermitte L; Chen R; Brouwer-De Cock KA; van der Linden A; Noordijk AL; Comans-Bitter WM; Staal FJ; van Dongen JJ;
    Leukemia; 2009 Jun; 23(6):1106-17. PubMed ID: 19387467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].
    Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K
    Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia].
    Rejtó L; Balázs M; Adány R; Rák K; Telek B; Kiss A; Ujj G; Mezei G; Balogh E; Udvardy M
    Orv Hetil; 2000 Sep; 141(39):2133-7. PubMed ID: 11028176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia.
    Lundán T; Juvonen V; Mueller MC; Mustjoki S; Lakkala T; Kairisto V; Hochhaus A; Knuutila S; Porkka K
    Haematologica; 2008 Feb; 93(2):178-85. PubMed ID: 18223279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
    Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
    Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific assessment of BCR-ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients.
    Bianchini M; De Brasi C; Gargallo P; Gonzalez M; Bengió R; Larripa I
    Eur J Haematol; 2009 Apr; 82(4):292-300. PubMed ID: 19191867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
    Yujie W; Yu Z; Sixuan Q; Li W; Peng L; Zeng G; Sujiang Z; Jianyong L
    Leuk Lymphoma; 2012 Mar; 53(3):451-5. PubMed ID: 21933042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia in the course of chronic myelocytic leukemia: evidence of independent clonal origin as shown by interphase fluorescence in situ hybridization and fluorescence-activated cell sorting.
    Chang H; Sutherland R; Nayar R; Li D; Kamel-Reid S; Mile MA; Messner H; Lipton J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):146-8. PubMed ID: 15262435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of chronic myelogenous leukemia with e8a2 fusion transcript.
    Park IJ; Lim YA; Lee WG; Park JS; Kim HC; Lee HJ; Cho SR
    Cancer Genet Cytogenet; 2008 Sep; 185(2):106-8. PubMed ID: 18722880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
    Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
    Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis of myeloproliferative neoplasms.
    Patnaik MM; Tefferi A
    Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular detection of the BCR-ABL gen by RT-PCR in Costa Rican children with leukemia].
    Jiménez-Arce G; Carrillo J; Chaves M; Jiménez R; Vargas M; Campos L; de la Guardia A; Valverde B
    Rev Biol Trop; 2008 Dec; 56(4):1613-8. PubMed ID: 19419069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
    Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
    Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization for BCR-ABL.
    Drummond MW; Allan EK; Pearce A; Holyoake TL
    Methods Mol Med; 2004; 97():103-16. PubMed ID: 15064488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.